The Valley Desk

NCT04029116 · Interventional trial

Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)

Overall registry status Completed

Phase 3

Conditions Recurrent Vulvovaginal Candidiasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov